Lateral Flow Assays for Pathogens of the Plague
Conditions:   Plague;   Plague, Bubonic;   Plague, Pneumonic;   Yersinia Pestis Plague;   Yersinia Pestis; Bubo;   Yersinia Pestis; Pneumonia;   Yersinia Sepsis;   Yersinia Pestis Infection;   Bubo; Yersinia Pestis;   Bubonic; Plague, Skin;   Pneumonic Plague Intervention:   Diagnostic Test: Lateral Flow Assay for Pathogens of the Plague Sponsors:   Brimrose Technology Corporation;   Northern Arizona University;   New Horizons Diagnostics Corporation;   Institut Pasteur de Madagascar;   Naval Health Research Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2020 Category: Research Source Type: clinical trials

An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial
DiscussionIf successful, the trial has the potential to inform the standard of care guidelines not just in Madagascar but in other countries afflicted by plague. The trial is currently ongoing and expected to complete recruitment in 2022.Trial registrationClinicalTrials.govNCT04110340. Registered on 1 October 2019 (Source: Trials)
Source: Trials - August 16, 2020 Category: Research Source Type: clinical trials

Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study
Condition:   Schistosomiasis Interventions:   Drug: Praziquantel 600Mg Oral Tablet x 5;   Drug: Praziquantel 600Mg Oral Tablet x 1 Sponsors:   Vendsyssel Hospital;   Charite University, Berlin, Germany;   Leiden University Medical Center;   Nagasaki University;   Umeå University;   Merck Serono International SA;   Ministry of Health, Madagascar Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2019 Category: Research Source Type: clinical trials